Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian Aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial

Leach, Amanda J., Wood, Yvonne, Gadil, Edna, Stubbs, Elizabeth and Morris, Peter S. (2008). Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian Aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial. Pediatric Infectious Disease Journal,27(8):692-698.

Document type: Journal Article

IRMA ID 10016xPUB15
Title Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian Aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial
Author Leach, Amanda J.
Wood, Yvonne
Gadil, Edna
Stubbs, Elizabeth
Morris, Peter S.
Journal Name Pediatric Infectious Disease Journal
Publication Date 2008
Volume Number 27
Issue Number 8
ISSN 0891-3668   (check CDU catalogue open catalogue search in new window)
Start Page 692
End Page 698
Total Pages 7
Place of Publication US
Publisher Lippincott Williams & Wilkins
Field of Research 1114 - Paediatrics and Reproductive Medicine
HERDC Category C1 - Journal Article (DEST)
Abstract Background
Chronic suppurative otitis media (CSOM) affects many children in disadvantaged populations. The most appropriate topical antibiotic treatment in children with persistent disease is unclear.

Methods
Children with CSOM despite standard topical treatment were randomized to 6-8 weeks of topical ciprofloxacin (CIP) versus topical framycetin-gramicidin-dexamethasone (FGD). Otoscopic, audiologic, and microbiologic outcomes were measured using standardized assessments and blinding.

Results
Ninety-seven children were randomized. Ear discharge failed to resolve at the end of therapy in 70% children regardless of allocation [risk difference = -2%; (95% CI: -20 to 16)]. Healing of the tympanic membrane occurred in one of 50 children in the CIP group and none of 47 children in the FGD group. Severity of discharge failed to improve in more than 50% children in each group, and mean hearing threshold (38 dB and 35 dB) and proportion of children with greater than 25 dB hearing loss (98% and 88%) were not significantly different between the CIP and FGD groups. Side effects were rare.

Conclusions
This study showed a similarly low rate of improvement or cure in children with persistent CSOM for both CIP and FGD topical therapies. Complications and side effects were insufficient to cease therapy or inform prescribing of either therapy.
DOI http://dx.doi.org/10.1097/INF.0b013e31816fca9d   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
 
Versions
Version Filter Type
Access Statistics: 121 Abstract Views  -  Detailed Statistics
Created: Fri, 24 Apr 2009, 13:02:06 CST by Sarena Wegener